The KHA-CARI Guidelines is an evidence-based project that began in 1999. This project is funded by the Kidney Health Australia and is managed by the CARI Guidelines Steering Committee, a sub-committee of Dialysis Nephrology & Transplantation (DNT) committee, which reports to Kidney Health Australia and Australian and New Zealand Society of Nephrology (ANZSN).
Quick links to CARI Guideline cari.org.au content:
KHA-CARI Guidelines seeks to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of clinical practice guidelines based on the best available evidence and effectiveness.
Role of the KHA-CARI Office
The main role of the KHA-CARI Office is:
- To support guideline writers through the guideline development and revision processes.
- To organise peer and consumer review of new and revised guidelines.
- To identify relevant trials in the literature for each Working Group (with the assistance of the Cochrane Renal Group).
- To obtain full text copies of papers as requested by guideline writers.
- To edit completed sets of guidelines and arrange for their publication on the KHA-CARI site.
- To maintain the KHA-CARI guidelines website and produce the KHA-CARI newsletter.
Important quick links
Ensuring the use of KHA-CARI Guidelines in clinical practice
Guidelines are an important aspect of quality patient care. They provide clinicians with recommendations that help them to practice evidence based medicine. The overall purpose of clinical guidelines is to improve health outcomes and to encourage the appropriate use of resources.
Guidelines are static entities if not put into practice. It takes a motivated team to change practice and incorporate a guideline into daily patient care. An essential part of the guideline development process is the formulation of a dissemination and implementation strategy.
KHA-CARI Guidelines staff has been and are continuing to research the best methods for ensuring the use of guidelines in clinical practice. Implementation projects are undertaken to assess both the impact of KHA-CARI Guidelines on clinical practice as well as the barriers faced by renal units in the implementation of KHA-CARI Guidelines. As implementation projects progress, KHA-CARI will develop tools to assist in guideline implementation.
Criteria used to identify which recommendations should be actively implemented include:
- the presence of a strong evidence base supporting the recommendation
- clinical importance
- existence of a clear evidence/practice gap
- patient burden of disease is high
- ability to measure a change in practice
- feasibility of development of an implementation strategy
Implementation projects are generally conducted according to three prime steps name
Phase I: Establish current practices and protocols
Phase II: Conduct implementation trial
Page updated 2 July 2015